Autoimmune diseases: distinct disorders or diverse manifestations of a common pathogenic process?

Autoimmune diseases arise from the amplification of natural autoreactive immune clones in genetically susceptible individuals under the influence of environmental triggers, epigenetic modifications, and hormonal factors. They comprise a broad and heterogeneous group of disorders characterized by immune-mediated tissue injury and dysfunction. More than 80 autoimmune diseases have been identified, affecting nearly every organ system. Although these disorders exhibit distinct clinical phenotypes and tissue specificity, many share common clinical manifestations, autoantibody profiles, genetic susceptibility loci, epigenetic alterations, and immunopathogenic mechanisms. Alterations in the composition of the microbiome (dysbiosis) have also been implicated in the development and progression of several autoimmune diseases. Furthermore, aberrant B-cell activation, impaired regulatory T-cell function, dysregulated type I interferon signaling, and chronic tissue-specific immune responses contribute to disease pathogenesis. The management of systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome (autoimmune epithelitis), systemic sclerosis, Idiopathic inflammatory myopathies, mixed connective tissue disease, and systemic vasculitis, is increasingly guided by the nature and severity of clinical manifestations and the dominant immunopathological pathways rather than by traditional disease classifications alone. This review examines whether autoimmune diseases should be regarded as distinct clinical entities or as diverse manifestations of shared immunopathological processes. By analyzing common clinical features, autoantibody profiles, tissue-specific immune responses, environmental influences, genetic susceptibility, epigenetic regulation, and therapeutic approaches, we highlight both the unifying mechanisms and the distinguishing characteristics that shape autoimmune disease expression. Collectively, the available evidence supports the concept that autoimmune diseases represent a spectrum of interconnected disorders that share common pathogenic pathways while maintaining disease-specific patterns of tissue involvement.